Phase I. Trial of irinotecan plus carboplatin in two dose schedules.
Jones SF, Burris HA 3rd, Hainsworth JD, Yardley DA, Raefsky EA, Miranda FT, Kuzur ME, Willcutt NT, White MB, Greco FA.
Jones SF, et al. Among authors: yardley da.
Oncology (Williston Park). 2003 May;17(5 Suppl 5):36-40.
Oncology (Williston Park). 2003.
PMID: 12800605
Review.